Pharmacometabolomics in TB meningitis—Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid
PLOS ONE · 03.03.2025 · 20 (3) · e0315999
DOI: 10.1371/journal.pone.0315999 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 03.03.2025. Verfasst von Jeffrey M Collins und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America. Hauptthemen laut MEDLINE: Tuberculosis, Meningeal, Antitubercular Agents, Metabolomics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, FIC NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Poor penetration of many anti-tuberculosis (TB) antibiotics into the central nervous system (CNS) is thought to be a major driver of morbidity and mortality in TB meningitis (TBM). While the amount of a particular drug that crosses into the cerebrospinal fluid (CSF) varies from person to person, little is known about the host factors associated with interindividual differences in CSF concentrations of anti-TB drugs. In patients diagnosed with TBM from the country of Georgia (n = 17), we investigate the association between CSF concentrations of anti-TB antibiotics and multiple host factors including serum drug concentrations and CSF concentrations of metabolites and cytokines. We found > 2-fold differences in CSF concentrations of anti-TB antibiotics from person to person for all drugs tested including cycloserine, ethambutol, imipenem, isoniazid, levofloxacin, linezolid, moxifloxacin, pyrazinamide, and rifampin. While serum drug concentrations explained over 30% of the variation in CSF drug concentrations for cycloserine, isoniazid, linezolid, and pyrazinamide (adjusted R 2 ≥ 0.3, p < 0.001 for all), there was no significant association between serum concentrations of imipenem and ethambutol and their respective CSF concentrations. CSF concentrations of carnitines were significantly associated with concentrations of ethambutol and imipenem (q < 0.05), and imipenem was the only antibiotic significantly associated with CSF cytokine concentrations. These results indicate that there is high interindividual variability in CSF drug concentrations in patients treated for TBM, which is only partially explained by differences in serum drug concentrations. With the exception of imipenem, there was no association between CSF drug concentrations and concentrations of cytokines and chemokines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
- National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
- The University of Georgia, Tbilisi, Georgia.
- David Tvildiani Medical University, The University of Georgia, Tbilisi, Georgia.
- Department of Biostatistics, Rollins School of Public Health of Emory University, Atlanta, Georgia, United States of America.
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
ORCID-Profile: Jeffrey M Collins, Yutong Jin, Charles Peloquin, Russell R Kempker
Förderung
- NIAID NIH HHS
- FIC NIH HHS
- NCATS NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Center for Advancing Translational Sciences
- Fogarty International Center
Zitieren
APA
Collins, J. M., Kipiani, M., Jin, Y., Sharma, A. A., Tomalka, J. A., Avaliani, T., Gujabidze, M., Bakuradze, T., Sabanadze, S., Avaliani, Z., Blumberg, H. M., Benkeser, D., Jones, D. P., Peloquin, C., & Kempker, R. R. (2025). Pharmacometabolomics in TB meningitis—Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid. PLOS ONE, 20(3), e0315999. https://doi.org/10.1371/journal.pone.0315999
Vancouver
Collins JM, Kipiani M, Jin Y, Sharma AA, Tomalka JA, Avaliani T, et al. Pharmacometabolomics in TB meningitis—Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid. PLOS ONE. 2025;20(3):e0315999. doi:10.1371/journal.pone.0315999
BibTeX
@article{Collins2025,
author = {Collins, Jeffrey M and Kipiani, Maia and Jin, Yutong and Sharma, Ashish A and Tomalka, Jeffrey A and Avaliani, Teona and Gujabidze, Mariam and Bakuradze, Tinatin and Sabanadze, Shorena and Avaliani, Zaza and Blumberg, Henry M and Benkeser, David and Jones, Dean P and Peloquin, Charles and Kempker, Russell R},
title = {Pharmacometabolomics in TB meningitis—Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {3},
pages = {e0315999},
doi = {10.1371/journal.pone.0315999}
}
EUVIMED